[ 5/9 (수) ]
KPAC 2018 (Korea Pharma Associations Conference/한국제약산업공동컨퍼런스)

담당자 정보	임현희, +82-2-6263-2058, hyunhee.leem@mci-group.kr

시간	주제
13 : 00 ~ 14 : 00	Registration
14 : 00 ~ 14 : 10	Opening Remarks
	KPBMA / KRPIA
14 : 10 ~ 14 : 25	Congratulatory Remarks
	Minister of MOHW / M
14 : 25 ~ 14 : 30	Photo Time
14 : 30 ~ 15 : 10	Keynote Speech
	Philip Tagari, VP of Research, AMGEN
패널토론
15 : 10 ~ 16 : 20	Session 1: Future of Oncology Biomarkers and How Open Innovation Works
	Kiyoshi Hashigami, Head of Medical & Development for Japan, Korea and Taiwan, BMS
	Byoung Chul Cho, Professor, Div. of Medical Oncology, Severance Hospital
	Rosa Heejung Kim, Sr. Manager. IMED Biotech, AstraZeneca
	Harry Hunwoo Shin, Director, BD&Licensing, MSD
16 : 40 ~ 17 : 50	Session 2: Implement ‘Quick Win Fast Fail Strategy’ for New Drug R&D
	Birgit Reitmaier, Head of Access to Innovation APAC, Merck
	Takao Honda, Sr. Manager, External Innovation, Eli Lilly Japan
	Su Jin Ahn, Director of DMPK of Yuhan R&D Institute, Yuhan
	Kouichi Akahane, Head of Oncology Function of R&D Div, Daiichi Sankyo